Investigating the predictors and progression of cardiovascular disease in diverse populations
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) COORDINATING CENTER (CC) - TASK AREA B EXAM 7
The Multi-Ethnic Study of Atherosclerosis (MESA) is looking for people aged 45-84 who don’t have heart disease to help us learn how heart health changes over time, using special tests and scans to spot any early signs of heart issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10470548 on NIH RePORTER |
What this research studies
The Multi-Ethnic Study of Atherosclerosis (MESA) examines how subclinical cardiovascular disease develops and progresses in a diverse group of individuals aged 45-84 who initially showed no signs of heart disease. This research involves advanced imaging techniques and regular follow-ups to track health changes over time. Participants undergo various tests, including CT scans and ultrasounds, to assess their cardiovascular health and identify risk factors. The study aims to understand the relationship between early signs of heart disease and later clinical outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are men and women aged 45-84 from diverse ethnic backgrounds who do not have clinical cardiovascular disease.
Not a fit: Patients who already have diagnosed cardiovascular disease or are outside the age range may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for early detection and prevention of cardiovascular disease in diverse populations.
How similar studies have performed: Previous studies on cardiovascular disease have shown success in identifying risk factors and improving early detection methods, making this research a continuation of established findings.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Mcclelland, Robyn — University of Washington
- Study coordinator: Mcclelland, Robyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.